Krebs Biochemicals & Industries Ltd - Business Profile with Financial and SWOT Analysis
US$ 200.00
Krebs Biochemicals & Industries Ltd - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Kukje Pharmaceutical Industrial Co. Ltd. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Kukje Pharmaceutical Industrial Co. Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Kun Run Biotechnology, Inc. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Kun Run Biotechnology, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Kunming Pharmaceutical Corp Ltd. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Kunming Pharmaceutical Corp Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
KunWha Pharmaceutical Co., Ltd. - Business Profile with Financial and SWOT Analysis
US$ 200.00
KunWha Pharmaceutical Co., Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
KV Pharmaceutical Co. - Business Profile with Financial and SWOT Analysis
US$ 200.00
KV Pharmaceutical Co. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Kwang Dong Pharmaceutical Co., Ltd. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Kwang Dong Pharmaceutical Co., Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
KYORIN Holdings, Inc. - Business Profile with Financial and SWOT Analysis
US$ 200.00
KYORIN Holdings, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Kyowa Hakko Kirin Co., Ltd. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Kyowa Hakko Kirin Co., Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Kyto BioPharma Inc. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Kyto BioPharma Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Kyung Dong Pharmaceutical Co., Ltd. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Kyung Dong Pharmaceutical Co., Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Kyung Nam Pharm Co., Ltd. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Kyung Nam Pharm Co., Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
La Jolla Pharmaceutical Co. - Business Profile with Financial and SWOT Analysis
US$ 200.00
La Jolla Pharmaceutical Co. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
LAB Research, Inc. - Business Profile with Financial and SWOT Analysis
US$ 200.00
LAB Research, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Labopharm Inc. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Labopharm Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Laboratorios Almirall SA - Business Profile with Financial and SWOT Analysis
US$ 200.00
Laboratorios Almirall SA - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Laboratorios Andromaco S.A. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Laboratorios Andromaco S.A. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Laboratorios Farmaceuticos ROVI, S.A. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Laboratorios Farmaceuticos ROVI, S.A. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Laboratorios Farmindustria S.A. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Laboratorios Farmindustria S.A. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Lactose (India) Ltd. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Lactose (India) Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Lannett Company, Inc. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Lannett Company, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Lansen Pharmaceutical Holdings Co., Ltd - Business Profile with Financial and SWOT Analysis
US$ 200.00
Lansen Pharmaceutical Holdings Co., Ltd - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Lavipharm SA - Business Profile with Financial and SWOT Analysis
US$ 200.00
Lavipharm SA - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Layerlab AB - Business Profile with Financial and SWOT Analysis
US$ 200.00
Layerlab AB - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Lee's Pharmaceutical Holdings Ltd. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Lee's Pharmaceutical Holdings Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Lescarden Inc. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Lescarden Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Lexicon Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Lexicon Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
LG Life Sciences Ltd. - Business Profile with Financial and SWOT Analysis
US$ 200.00
LG Life Sciences Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Life Nutrition Products, Inc. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Life Nutrition Products, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Life Technologies Corp. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Life Technologies Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
LifeCycle Pharma A/S - Business Profile with Financial and SWOT Analysis
US$ 200.00
LifeCycle Pharma A/S - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
LifeHealthCare Inc. - Business Profile with Financial and SWOT Analysis
US$ 200.00
LifeHealthCare Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Lifevantage Corp. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Lifevantage Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Ligand Pharmaceuticals Inc. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Ligand Pharmaceuticals Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Lightlake Therapeutics Inc - Business Profile with Financial and SWOT Analysis
US$ 200.00
Lightlake Therapeutics Inc - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Lijun International Pharmaceutical (Holding) Co Ltd. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Lijun International Pharmaceutical (Holding) Co Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Lincoln Pharmaceuticals Ltd. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Lincoln Pharmaceuticals Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Linical Co., Ltd. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Linical Co., Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
LipidViro Tech Inc. - Business Profile with Financial and SWOT Analysis
US$ 200.00
LipidViro Tech Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Living Cell Technologies Ltd. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Living Cell Technologies Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Livzon Pharmaceutical Group Inc. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Livzon Pharmaceutical Group Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Lixte Biotechnology Holdings, Inc. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Lixte Biotechnology Holdings, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Long-e International, Inc. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Long-e International, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Lonza Group AG - Business Profile with Financial and SWOT Analysis
US$ 200.00
Lonza Group AG - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Lorus Therapeutics Inc. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Lorus Therapeutics Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Lotus Pharmaceutical Co Ltd. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Lotus Pharmaceutical Co Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Lotus Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Lotus Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Lpath Inc. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Lpath Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
LTT Bio-Pharma Co. Ltd. - Business Profile with Financial and SWOT Analysis
US$ 200.00
LTT Bio-Pharma Co. Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages
Luminex Corp. - Business Profile with Financial and SWOT Analysis
US$ 200.00
Luminex Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
November 2026
30 pages